01 AMLODIPINE BESYLATE (1)
02 AMLODIPINE BESYLATE (PROCESS 2) (1)
03 APREMILAST (1)
04 ATORVASTATIN CALCIUM (1)
05 AURANOFIN (1)
06 BROMOCRIPTINE MESYLATE USP (1)
07 CALCIUM (GLUCOHYTONATE) GLUCEPTATE (1)
08 CANDESARTAN CILEXETIL (1)
09 CASPOFUNGIN ACETATE (1)
10 CIMETIDINE HCL (1)
11 CLAVULANATE POTASSIUM (1)
12 CLAVULANATE POTASSIUM DILUTED WITH SILICON DIOXIDE 1:1 (1)
13 DIHYDROERGOTAMINE MESYLATE (1)
14 DOLUTEGRAVIR SODIUM (1)
15 ENALAPRIL MALEATE, ACTIVE SUBSTANCE (1)
16 ENTECAVIR MONOHYDRATE (1)
17 FDA DATA AND REFERENCE MATERIAL: HISTORICAL CONTROL FOR EPILEPSY MONOTHERAPY CLINICAL TRIALS (1)
18 FERRIC CARBOXYMALTOSE (1)
19 FERUMOXYTOL (1)
20 FESOTERODINE FUMARATE (1)
21 GENTAMICIN SULFATE (1)
22 LISINOPRIL ACTIVE DRUG SUBSTANCE (1)
23 LITHIUM CARBONATE (1)
24 LITHIUM CARBONATE ACTIVE SUBSTANCE (1)
25 LOSARTAN POTASSIUM (1)
26 LOVASTATIN (1)
27 LOVASTATIN ACTIVE DRUG SUBSTANCE (1)
28 MYCOPHENOLATE MOFETIL (1)
29 MYCOPHENOLATE MOFETIL (PROCESS B), USP (1)
30 NIFEDIPINE (1)
31 OLANZAPINE (1)
32 OMEPRAZOLE ACTIVE DRUG SUBSTANCE (1)
33 POTASSIUM CLAVULANATE DILUTED WITH MICROCRYSTALLINE CELLULOSE IN THE RATIO 1:1 (1)
34 POTASSIUM CLAVULANATE DILUTED WITH SILICON DIOXIDE IN THE RATIO 1:1 (1)
35 PRAVASTATIN SODIUM (2)
36 PROPRANOLOL HCL (1)
37 RAPAMYCIN (1)
38 ROSUVASTATIN CALCIUM (1)
39 ROSUVASTATIN CALCIUM (PROCESS B) (1)
40 ROSUVASTATIN CALCIUM (PROCESS C) (1)
41 SILVER SULFADIAZINE (1)
42 SIMVASTATIN (1)
43 SUGAMMADEX SODIUM (1)
44 TACROLIMUS (1)
45 TACROLIMUS (PROCESS II) (1)
46 TAMSULOSIN HYDROCHLORIDE (1)
47 TICAGRELOR (1)
48 TOLTERODINE TARTRATE (1)
49 VANCOMYCIN HYDROCHLORIDE (2)
50 VORTIOXETINE HYDROBROMIDE (1)
01 LEK PHARMACEUTICAL AND CHEMICAL CO DD (9)
02 LEK PHARMACEUTICALS DD (41)
03 NOVARTIS PHARMACEUTICAL CORP (1)
04 NOVARTIS PHARMACEUTICALS CORP (1)
01 Slovenia (52)
01 Active (26)
02 Inactive (26)
01 Complete (14)
02 Blank (38)